The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.28.2.125

In a study to evaluate the effectiveness of specific pharmacological treatment groups, former VA inpatients who have similar diagnoses and respond satisfactorily to drug treatment join a Prolixin group, a lithium group, or an affective disorder group. In monthly meetings the patients learn about their illness, the importance of taking medication as prescribed, and possible side-effects; they also receive psychological support. The 85 patients who joined the groups during the first 12 months attended 87.3 per cent of the sessions. Twenty per cent of them were rehospitalized, about half of them because they did not take medication as prescribed. The authors believe the groups are an economical and effective way to provide aftercare.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.